Evidence map›Paper›PMID 26869655›Full record

ArticleJournal of oncology practice2016

ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy.

Caitriona B O'Neill, Coral L Atoria, Eileen M O'Reilly, Martin C Henman, Peter B Bach, Elena B Elkin, Caitriona B O'Neill, Coral L Atoria, Eileen M O'Reilly, Martin C Henman and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Unplanned emergency department visits and hospital admissions of older adults under treatment for cancer in the ambulatory/community setting.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  11. Impact of care pathway for nursing home residents treated for cancer: ONCO-EHPAD study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Management and survival analysis of elderly patients with a cancer in the digestive system who refused to receive anticancer treatments.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Caitriona B O'NeillMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Coral L AtoriaMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Eileen M O'ReillyMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Martin C HenmanMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Peter B BachMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Elena B ElkinMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland elkine@mskcc.org.
Caitriona B O'NeillMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Coral L AtoriaMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Eileen M O'ReillyMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Martin C HenmanMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Peter B BachMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland.
Elena B ElkinMemorial Sloan Kettering Cancer Center, New York, NY; and Trinity College Dublin, Dublin, Ireland elkine@mskcc.org.
Memorial Sloan Kettering Cancer Center · USTrinity College Dublin · IE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748
6 · The paper itself

Abstract

purposeHospital readmissions are often cited as a marker of poor quality of care. Limited data suggest some readmissions may be preventable depending upon definitions and available outpatient support.

methodsGeneral criteria to define preventable and not preventable admissions were developed before data collection began. The records of sequential nonsurgical oncology readmissions were reviewed independently by two reviewers. When the reviewers disagreed about assigning admissions as preventable or not preventable, a third reviewer was the tie breaker. The reasons for assigning admissions as preventable or not preventable were analyzed.

resultsSeventy-two readmissions occurring among 69 patients were analyzed. The first two reviewers agreed that 18 (25%) of 72 were preventable and that 29 (40%) of 72 were not. A third reviewer found four of the split 25 cases to be preventable; therefore, the consensus preventability rate was 22 (31%) of 72. The most common causes of preventability were overwhelming symptoms in patients who qualified for hospice but were not participating in hospice and insufficient communication between patients and the care team about symptom burden. The most common reason for assignment of a not preventable admission was a high symptom burden among patients without strong indications for hospice or for whom aggressive outpatient management was inadequate. The median survival after readmission was 72 days.

conclusionA substantial proportion of oncology readmissions could be prevented with better anticipation of symptoms in high-risk ambulatory patients and enhanced communication about symptom burden between patients and physicians before an escalation that leads to an emergency department visit. Managing symptoms in patients who are appropriate for hospice is challenging. Readmission is a marker of poor prognosis.

Indexed as

HospitalizationAgedAged, 80 and overAge FactorsAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyComorbidityFemaleHumansMaleNeoplasmsNeoplasm StagingSEER Program

Identifiers

PMID26869655
PMCPMC5702789
OpenAlexW2256739218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.